Topic Archives: Aurinia Pharmaceuticals (AUPH)

No, Balthasar is not a biotech company. Think fast! Aragorn, Legolas and Gimli. Athos, Porthos and Aramis. Jaclyn, Farrah and Kate. Kirk, Spock and Bones. Barry, Robin and Maurice. Shadrach, Meshach and Abednego. History and culture bestow trios upon us because threesomes keep us rapt. The Three Magi, liking the Gummune as they do, have […]

[Ed. Note: Dr. KSS is our biotech and medical maven, who writes for the Irregulars. He has agreed to our trading restrictions, chooses is own topics, and his words and opinions are his own. You can find all of his previous articles and most recent comments on his Stock Gumshoe page.] Although the drive to […]

Glenn Newberry in an earlier post today was asking whether Benlysta from GlaxoSmithKline (GSK), being trialled for lupus nephritis, poses any threat to Aurinia (AUPH). Benlysta is a monoclonal antibody that binds to and inhibits BAFF (B-cell activating factor). A company called Anthera (ANTH) is trialling blisibimod, an oral agent that does the same thing. […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He chooses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions. To see all of his column and his latest comments, go to his Stock Gumshoe page.] [Author’s note: This commentary has been […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. All of his past articles and most recent comments are on his Stock Gumshoe page.] “Peaches come from a can They were put […]

[Ed. Note: Dr. KSS writes for our Irregulars about medicine and biotech stocks. As always, he has agreed our trading restrictions, and his words and opinions are his own. You can find all of his previous articles here. And now, for some dim sum….] Greetings Irregulars, and welcome to Stock Gumshoe’s festive second BioDimSum shindig, a periodic round-up […]

Comments

  • Avatar

    Dr KSS was right on this one!...

  • SoGiAm

    $AUPH Aurinia’s offering looks to have been upsized: As PR’ed in AM — $150 mil $22.5 mil greenshoe As pri...

  • Avatar

    Hi, I started following KSS here, and moved over to BioPub as well. I have substantial positions in over a dozen of his...

  • Avatar

    $auph np Hi Joe S..Any thoughts on today's runup on auph? I didn't see any news..some boards inficated a large block sol...

  • Avatar

    AUPH- Aurinia Announces Voclosporin Ophthalmic Solution Demonstrates Statistically Superior Efficacy Versus Restasis® ...

  • SoGiAm

    Glickman plans to retire, but will stay on for as long as it takes to find a worthy replacement, e.g., could be a year o...

  • SoGiAm

    $AUPH Aurinia to Participate in November Investor Conferences https://ir.auriniapharma.com/press-releases/detail/127 Be...

  • SoGiAm

    $AUPH > Aurinia Pharmaceuticals to Release Third Quarter Financial Results and General Business Updates on November 8, 2...

  • SoGiAm

    $AUPH small position > Reduced to increase :-) KASH :-) & :-) CASH :-) in After hours trading this p.m.. #Best2YOU!...

  • SoGiAm

    $AUPH ow > :-) We are #ELATED… :-) Details in MODERATION Lynn, and in press release above or below! :-) Thank YOU 4...

  • SoGiAm

    $AUPH WOW > We are #ELATED... VICTORIA, British Columbia--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH...

  • SoGiAm

    $AUPH ow > Aurinia Completes Enrollment of AURORA, its Phase 3 Clinical Trial for the Treatment of Lupus Nephritis Clic...

  • SoGiAm

    Arch Therapeutics to Provide Corporate Update at the H.C. Wainwright 20th Annual Global Investment Conference on Wednesd...

  • LongOnLife

    $AUPH news... https://www.businesswire.com/news/home/20180220006518/en/...

  • LongOnLife

    $AUPH https://investorshub.advfn.com/boards/read_msg.aspx?message_id=138494141 Fireside chat with CEO Glickman and his...

  • LongOnLife

    $AUPH news: https://finance.yahoo.com/news/aurinia-pharmaceuticals-launches-lupus-nephritis-130000002.html...

  • Avatar

    tyler123dogfiddle - thank you for your views on Stephen Goldman. I believe the future of the Gummune will be dependent ...

  • Avatar

    Hi all. As it seems this is a beginning of something new I also wanted to bring another company up for discussion. Nothi...

  • Avatar

    Dr KSS, assuming the Biotech Showcase 2018 is over, what would you present as your current list of best opportunities in...

  • Avatar

    $AUPH Dr KSS I would appreciate your perspective on when Aurinia might file for a patent extension on Voclosporin. How ...

  • Avatar

    Thank you Doc for the update on $AUPH I for one will stay the course, it's very easy to develop doubts with the "nois...

  • Avatar

    $AUPH Fellow Gummies, dr KSS, I'm sure you are aware of this development that should interest anyone interested in Auri...

  • SoGiAm

    $AUPH fp - Aurinia Pharmaceuticals Added to the NASDAQ Biotech Index Click here to read the full article https://ir....

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info